Spotlight on ...

Spotlight on ...

Immunohistochecmistry

The role of immunohistochemistry in patient stratification and personalised medicine

Not all patients respond well to treatment and drugs have failed in the clinic due to “all patient” designs. Immunohistochemistry (IHC) could be used to group patients according to the expression levels of a specific biomarker. With successful validation and quantification, IHC assays can play a vital role in drug development as a method of patient stratification.